Cargando…
Molecular and Cellular Bases of Lipodystrophy Syndromes
Lipodystrophy syndromes are rare diseases originating from a generalized or partial loss of adipose tissue. Adipose tissue dysfunction results from heterogeneous genetic or acquired causes, but leads to similar metabolic complications with insulin resistance, diabetes, hypertriglyceridemia, nonalcoh...
Autores principales: | Zammouri, Jamila, Vatier, Camille, Capel, Emilie, Auclair, Martine, Storey-London, Caroline, Bismuth, Elise, Mosbah, Héléna, Donadille, Bruno, Janmaat, Sonja, Fève, Bruno, Jéru, Isabelle, Vigouroux, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763341/ https://www.ncbi.nlm.nih.gov/pubmed/35046902 http://dx.doi.org/10.3389/fendo.2021.803189 |
Ejemplares similares
-
Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019) -
Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
por: Mosbah, Héléna, et al.
Publicado: (2022) -
Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice
por: Mosbah, Héléna, et al.
Publicado: (2020) -
SUN-037 Diagnosis Challenge in Type 4 Familial Partial Lipodystrophic Syndrome
por: Vantyghem, Marie-Christine, et al.
Publicado: (2019) -
Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)